Deferoxamine therapy for intracerebral hemorrhage
Authors:
- 1 January 2008
- book chapter
- Published by Springer Nature
- Vol. 105, 3-6
Abstract
Intracerebral hemorrhage (ICH) is a subtype of stroke with very high mortality. Experiments have indicated that clot lysis and iron play an important role in ICH-induced brain injury. Iron overload occurs in the brain after ICH in rats. Intracerebral infusion of iron causes brain edema and neuronal death. Deferoxamine, an iron chelator, is an FDA-approved drug for the treatment of acute iron intoxication and chronic iron overload due to transfusion-dependent anemia. Deferoxamine can rapidly penetrate the blood-brain barrier and accumulate in the brain tissue in significant concentration after systemic administration. We have demonstrated that deferoxamine reduces ICH-induced brain edema, neuronal death, brain atrophy, and neurological deficits. Iron chelation with deferoxamine could be a new therapy for ICH.Keywords
This publication has 37 references indexed in Scilit:
- A New Hippocampal Model for Examining Intracerebral Hemorrhage-Related Neuronal DeathStroke, 2007
- Brain Injury After Intracerebral HemorrhageStroke, 2007
- Iron and Iron-Handling Proteins in the Brain After Intracerebral HemorrhageStroke, 2003
- Hemoglobin-Induced Cytotoxicity in Rat Cerebral Cortical NeuronsStroke, 2002
- Desferrioxamine Induces Delayed Tolerance against Cerebral Ischemia in Vivo and in VitroJournal of Cerebral Blood Flow & Metabolism, 2002
- Role of Blood Clot Formation on Early Edema Development After Experimental Intracerebral HemorrhageStroke, 1998
- Perilesional Blood Flow and Edema Formation in Acute Intracerebral HemorrhageStroke, 1998
- Lobar Intracerebral Hemorrhage Model in PigsStroke, 1996
- Deferoxamine Reduces Early Metabolic Failure Associated With Severe Cerebral Ischemic Acidosis in DogsStroke, 1995
- Neurotoxicity of hemoglobin in cortical cell cultureNeuroscience Letters, 1993